کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
6117069 | 1217160 | 2015 | 26 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
The interleukin-1β-511 T > C (rs16944) gene polymorphism is associated with risk of developing silent myocardial ischemia in diabetic patients
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
MAFIL-1βIL-1RASMIinterleukin 1BIL-1 receptor antagonist - آنتاگونیست گیرنده IL-1Silent myocardial infarction - انفارکتوس قلب خاموشSilent myocardial ischemia - ایسکمی قلب خاموشInterleukin-1 beta - اینترلوکین-1 بتاHaplotypes - هاپلوتیپPolymorphisms - پلی مورفیسمSingle nucleotide polymorphism - پلیمورفیسم تک نوکلئوتیدیSNP - چندریختی تک-نوکلئوتیدGenetic - ژنتیک
موضوعات مرتبط
علوم زیستی و بیوفناوری
ایمنی شناسی و میکروب شناسی
ایمونولوژی
پیش نمایش صفحه اول مقاله
چکیده انگلیسی
Silent myocardial ischemia (SMI) is a multifactorial and polygenic disorder that results from an excessive inflammatory response. Considering the prominent role of IL-1β, IL-1F10 and IL-1RN as regulators of the inflammatory process and vascular physiology, the aim of the present study was to analyze whether IL-1β, IL-1F10 and IL-1RN single nucleotide polymorphisms (SNPs) are associated with SMI. One polymorphism was associated with risk of SMI. Under co-dominant, recessive and additive models, the IL-1β-511 T > C polymorphism was associated with increased risk of SMI when compared to healthy controls (OR = 4.68, 95%CI = 2.21-9.92, pCCo-dom = 0.0048; OR = 3.97, 95%CI = 1.97-7.99, pCRec = 0.0024; OR = 2.02, 95%CI = 1.41-2.90, pCAdd = 0.0024, respectively). All models were adjusted for gender, age and smoking. Linkage disequilibrium analysis showed four haplotypes (CTCC, CCTC, CCCT and CTCC) with increased frequency in SMI patients when compared to healthy controls (OR = 2.53, 95%CI = 1.47-4.36, pC = 0.0009, OR = 2.34, 95%CI = 1.15-4.74, pC = 0.02, OR = 2.44, 95%CI = 1.14-5.18, pC = 0.02, OR = 5.11, 95%CI = 1.37-19.05, pC = 0.01, respectively). In summary, our data suggest that the IL-1β-511 T > C polymorphism plays an important role in the development of SMI in diabetic patients. In addition, in our study was possible to distinguish one protective and four risk haplotypes for development of SMI.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Immunology Letters - Volume 168, Issue 1, November 2015, Pages 7-12
Journal: Immunology Letters - Volume 168, Issue 1, November 2015, Pages 7-12
نویسندگان
Gilberto Vargas-Alarcón, Miguel Cruz-López, Adán Valladares, Edith Álvarez-León, Teresa Juárez-Cedillo, Ãscar Pérez-Méndez, Jorge Escobedo de-la-Peña, Galileo Escobedo, Jose Manuel Fragoso,